tbResList Print — MushShi Mushroom Shiitake, AHCC

Filters: qv=25, qv2=%, rfv=%

Product

MushShi Mushroom Shiitake, AHCC
Features: immunoenhancer
Description: <b>Mushroom Shiitake</b>, Active hexose correlated compound<br>
Extracted from Basidiomycete mushrooms (eg, shiitake [Lentinula edodes]) that is purported to improve immune function.<br>
Summary:<br>
- Can significantly inhibit carcinogenesis and improve anti-tumor effects, thus increasing the effectiveness of cancer immunotherapy.<br>
- Enhanced abundance of Akkermansia in the intestine of those who responded positively to the ICI(immune checkpoint inhibitors).<br>
<br>
-Eat fermented foods then fibre to maintain them. Fruits and vegs for fibre Chicory
root for fibre (inulin which is main prebiotic)<br>
<br>
AHCC is mainly derived from the mycelium of Shiitake mushrooms.<br>
• It is rich in polysaccharides that are believed to enhance immune function.<br>
• The compound may influence various pathways in cancer, including boosting NK cell activity, modulating cytokine production, influencing the NF-kB inflammatory pathway, and reducing oxidative stress.<br>
<br>
Pathways:<br>
-Stimulate cytokine production (e.g., interleukins, tumor necrosis factor) and enhance the function of macrophages and dendritic cells.<br>

<a href="https://pubmed.ncbi.nlm.nih.gov/28727820/" > https://pubmed.ncbi.nlm.nih.gov/28727820/ </a>
<br>

Pathway results for Effect on Cancer / Diseased Cells

Cell Death

Bcl-2↓, 1,   Mcl-1↓, 1,   survivin↓, 1,  

Cell Cycle & Senescence

cycD1/CCND1↓, 1,  

Proliferation, Differentiation & Cell State

PTPN6↑, 1,   p‑STAT3↓, 1,  

Angiogenesis & Vasculature

VEGF↓, 1,  

Functional Outcomes

Pain↑, 1,  

Infection & Microbiome

CD8+↑, 1,  
Total Targets: 9

Pathway results for Effect on Normal Cells

Core Metabolism/Glycolysis

LAT↑, 1,  

Migration

FLRT2↑, 1,   GIT1↑, 1,  

Immune & Inflammatory Signaling

T-Cell↑, 1,  
Total Targets: 4

Research papers

Year Title Authors PMID Link Flag
2017The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based ChemotherapyWineeya SuknikhomPMC5464477https://pmc.ncbi.nlm.nih.gov/articles/PMC5464477/0
2017Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) ActivationJin Young Choi29111786https://pubmed.ncbi.nlm.nih.gov/29111786/0
2015AHCC Activation and Selection of Human Lymphocytes via Genotypic and Phenotypic Changes to an Adherent Cell Type: A Possible Novel Mechanism of T Cell ActivationLoretta OlamigokePMC4693114https://pmc.ncbi.nlm.nih.gov/articles/PMC4693114/0